US Stock MarketDetailed Quotes

NYMXF Nymox Pharmaceutical

Watchlist
  • 0.200
  • +0.010+5.26%
15min DelayClose Jul 1 16:00 ET
18.65MMarket Cap-4000P/E (TTM)

Nymox Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.29%-1.26M
-158.38%-909K
76.52%-988K
47.00%-5.21M
44.46%-1.25M
56.47%-1.31M
181.86%1.56M
-57.62%-4.21M
2.16%-9.82M
-33.55%-2.25M
Net income from continuing operations
30.52%-1.04M
-182.84%-1.11M
72.73%-1.39M
47.55%-6.58M
52.35%-1.34M
54.79%-1.49M
133.58%1.34M
-108.53%-5.09M
-6.81%-12.54M
-38.63%-2.81M
Depreciation and amortization
-32.79%41K
-7.94%58K
-7.81%59K
-1.97%249K
-4.69%61K
-3.17%61K
0.00%63K
0.00%64K
-4.87%254K
4.92%64K
Change In working capital
-406.59%-279K
148.68%111K
-62.55%270K
453.57%495K
60.27%-89K
49.18%91K
-138.06%-228K
225.17%721K
55.41%-140K
-376.60%-224K
-Change in receivables
400.00%3K
--0
--0
-57.14%3K
--0
-133.33%-1K
--1K
-40.00%3K
800.00%7K
50.00%-1K
-Change in inventory
----
----
--0
--0
----
----
----
--0
--0
--0
-Change in prepaid assets
-442.39%-499K
-72.82%28K
-300.00%-56K
544.44%116K
1,800.00%119K
22.03%-92K
119.15%103K
-114.58%-14K
113.85%18K
-118.92%-7K
-Change in payables and accrued expense
17.93%217K
125.00%83K
-55.46%326K
327.88%376K
3.70%-208K
4.55%184K
-160.14%-332K
208.12%732K
4.07%-165K
-163.41%-216K
Cash from discontinued investing activities
Operating cash flow
3.29%-1.26M
-158.38%-909K
76.52%-988K
47.00%-5.21M
44.46%-1.25M
56.47%-1.31M
181.86%1.56M
-57.62%-4.21M
2.16%-9.82M
-33.55%-2.25M
Investing cash flow
Cash flow from continuing investing activities
0
0
-3K
0
0
0
0
0
53.85%-6K
66.67%-4K
Net PPE purchase and sale
--0
--0
---3K
--0
--0
--0
--0
--0
53.85%-6K
66.67%-4K
Cash from discontinued investing activities
Investing cash flow
--0
--0
---3K
--0
--0
--0
--0
--0
53.85%-6K
66.67%-4K
Financing cash flow
Cash flow from continuing financing activities
2,111.67%1.21M
-62.52%690K
-101.51%-61K
-17.98%5.78M
11.86%-52K
-1.69%-60K
-74.51%1.84M
6,848.33%4.05M
-16.35%7.05M
-1.72%-59K
Net issuance payments of debt
-1,221.67%-793K
1,289.66%690K
-3.39%-61K
3.78%-229K
11.86%-52K
-1.69%-60K
3.33%-58K
1.67%-59K
10.19%-238K
-1.72%-59K
Net common stock issuance
--2M
--0
--0
-17.52%6.01M
--0
--0
-73.93%1.9M
--4.11M
-16.16%7.28M
--0
Cash from discontinued financing activities
Financing cash flow
2,111.67%1.21M
-62.52%690K
-101.51%-61K
-17.98%5.78M
11.86%-52K
-1.69%-60K
-74.51%1.84M
6,848.33%4.05M
-16.35%7.05M
-1.72%-59K
Net cash flow
Beginning cash position
-96.76%132K
-47.77%351K
69.04%1.4M
-77.01%830K
-13.94%2.7M
-34.37%4.07M
-23.64%672K
-77.01%830K
-31.07%3.61M
-41.44%3.14M
Current changes in cash
95.90%-56K
-106.44%-219K
-565.82%-1.05M
120.60%573K
43.73%-1.3M
55.34%-1.37M
-36.14%3.4M
94.21%-158K
-70.82%-2.78M
-31.81%-2.31M
End cash Position
-97.19%76K
-96.76%132K
-47.77%351K
69.04%1.4M
69.04%1.4M
-13.94%2.7M
-34.37%4.07M
-23.64%672K
-77.01%830K
-77.01%830K
Free cash flow
3.29%-1.26M
-158.38%-909K
76.44%-991K
47.03%-5.21M
44.56%-1.25M
56.47%-1.31M
181.86%1.56M
-57.51%-4.21M
2.23%-9.83M
-32.84%-2.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.29%-1.26M-158.38%-909K76.52%-988K47.00%-5.21M44.46%-1.25M56.47%-1.31M181.86%1.56M-57.62%-4.21M2.16%-9.82M-33.55%-2.25M
Net income from continuing operations 30.52%-1.04M-182.84%-1.11M72.73%-1.39M47.55%-6.58M52.35%-1.34M54.79%-1.49M133.58%1.34M-108.53%-5.09M-6.81%-12.54M-38.63%-2.81M
Depreciation and amortization -32.79%41K-7.94%58K-7.81%59K-1.97%249K-4.69%61K-3.17%61K0.00%63K0.00%64K-4.87%254K4.92%64K
Change In working capital -406.59%-279K148.68%111K-62.55%270K453.57%495K60.27%-89K49.18%91K-138.06%-228K225.17%721K55.41%-140K-376.60%-224K
-Change in receivables 400.00%3K--0--0-57.14%3K--0-133.33%-1K--1K-40.00%3K800.00%7K50.00%-1K
-Change in inventory ----------0--0--------------0--0--0
-Change in prepaid assets -442.39%-499K-72.82%28K-300.00%-56K544.44%116K1,800.00%119K22.03%-92K119.15%103K-114.58%-14K113.85%18K-118.92%-7K
-Change in payables and accrued expense 17.93%217K125.00%83K-55.46%326K327.88%376K3.70%-208K4.55%184K-160.14%-332K208.12%732K4.07%-165K-163.41%-216K
Cash from discontinued investing activities
Operating cash flow 3.29%-1.26M-158.38%-909K76.52%-988K47.00%-5.21M44.46%-1.25M56.47%-1.31M181.86%1.56M-57.62%-4.21M2.16%-9.82M-33.55%-2.25M
Investing cash flow
Cash flow from continuing investing activities 00-3K0000053.85%-6K66.67%-4K
Net PPE purchase and sale --0--0---3K--0--0--0--0--053.85%-6K66.67%-4K
Cash from discontinued investing activities
Investing cash flow --0--0---3K--0--0--0--0--053.85%-6K66.67%-4K
Financing cash flow
Cash flow from continuing financing activities 2,111.67%1.21M-62.52%690K-101.51%-61K-17.98%5.78M11.86%-52K-1.69%-60K-74.51%1.84M6,848.33%4.05M-16.35%7.05M-1.72%-59K
Net issuance payments of debt -1,221.67%-793K1,289.66%690K-3.39%-61K3.78%-229K11.86%-52K-1.69%-60K3.33%-58K1.67%-59K10.19%-238K-1.72%-59K
Net common stock issuance --2M--0--0-17.52%6.01M--0--0-73.93%1.9M--4.11M-16.16%7.28M--0
Cash from discontinued financing activities
Financing cash flow 2,111.67%1.21M-62.52%690K-101.51%-61K-17.98%5.78M11.86%-52K-1.69%-60K-74.51%1.84M6,848.33%4.05M-16.35%7.05M-1.72%-59K
Net cash flow
Beginning cash position -96.76%132K-47.77%351K69.04%1.4M-77.01%830K-13.94%2.7M-34.37%4.07M-23.64%672K-77.01%830K-31.07%3.61M-41.44%3.14M
Current changes in cash 95.90%-56K-106.44%-219K-565.82%-1.05M120.60%573K43.73%-1.3M55.34%-1.37M-36.14%3.4M94.21%-158K-70.82%-2.78M-31.81%-2.31M
End cash Position -97.19%76K-96.76%132K-47.77%351K69.04%1.4M69.04%1.4M-13.94%2.7M-34.37%4.07M-23.64%672K-77.01%830K-77.01%830K
Free cash flow 3.29%-1.26M-158.38%-909K76.44%-991K47.03%-5.21M44.56%-1.25M56.47%-1.31M181.86%1.56M-57.51%-4.21M2.23%-9.83M-32.84%-2.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg